
Daniel da Silva, PhD, MSc
About Me
Daniel da Silva, PhD. is an Assistant Professor of the Nash Family Department of Neuroscience. His research is primarily focused on integrative and translational approaches to investigate the molecular, cellular, and synaptic mechanisms contributing to individual vulnerability to Alcohol Use Disorder (AUD). He completed his postdoctoral work at the NIH/NIAAA in Dr. Alvarez's laboratory, where he focused on the neurobiology of compulsive behaviors. In this capacity, he conducted groundbreaking research that identified distinct molecules and circuits involved in the transition from hedonic alcohol consumption to compulsive use. Notably, he was the first to establish a connection between the Parkinson-related gene Lrrk2, the modulation of dopamine D1 receptors, and the regulation of alcohol consumption in both mice and humans. More recently, he employed cutting-edge techniques such as single-cell RNA-sequencing and multiomic approaches to identify candidate cellular and molecular changes driving compulsive alcohol drinking in mice.
Language
English
Position
ADJUNCT ASSOCIATE PROFESSOR | Neuroscience
Awards
2021
Young Investigator Award
European Society for Biomedical Research on Alcoholism
2020
Trainee Professional Development Award
Society for Neuroscience
2017
Best Ph.D. Thesis in Genetics
Universidade Federal de Minas Gerais
Research
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Almeida Da Silva E Silva has not yet completed reporting of Industry relationships.
Mount Sinai’s faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.